Kazano Dosage
Generic name: alogliptin and metformin
Drug class: Antidiabetic combinations
Medically reviewed by A Ras MD.
Recommended Adult Dosing
Dosage forms: TAB: 12.5 mg/500 mg, 12.5 mg/1000 mg
Diabetes mellitus, type 2
- [conversion from alogliptin plus metformin]
- Dose: 1 tab PO bid; Start: equivalent dose of each component in current regimen; Max: 25 mg/2000 mg/day; Info: give w/ meals; do not cut/crush/chew tab; hold tx for surgery if restricting food/fluid; D/C for iodinated contrast study if eGFR 30-60, hepatic dz hx, alcoholism hx, heart failure hx, or receiving contrast intra-arterially; restart after 48h if stable renal fxn
- [conversion from alogliptin]
- Dose: 1 tab PO bid; Start: 12.5 mg/500 mg PO bid; Max: 25 mg/2000 mg/day; Info: give w/ meals; do not cut/crush/chew tab; hold tx for surgery if restricting food/fluid; D/C for iodinated contrast study if eGFR 30-60, hepatic dz hx, alcoholism hx, heart failure hx, or receiving contrast intra-arterially; restart after 48h if stable renal fxn
- [conversion from metformin]
- Dose: 1 tab PO bid; Start: alogliptin 12.5 mg PO bid w/ current metformin dose PO bid; Max: 25 mg/2000 mg/day; Info: give w/ meals; do not cut/crush/chew tab; hold tx for surgery if restricting food/fluid; D/C for iodinated contrast study if eGFR 30-60, hepatic dz hx, alcoholism hx, heart failure hx, or receiving contrast intra-arterially; restart after 48h if stable renal fxn
Renal dosing
- eGFR 30-60: avoid use; dose adjustment not possible w/ fixed-dose combo; eGFR <30: contraindicated
- HD/PD: avoid use
Hepatic dosing
- hepatic impairment: avoid use
SRC: NLM .